1552 related articles for article (PubMed ID: 19333946)
1. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
2. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells.
Gonzalez-Rey E; Chorny A; Varela N; O'Valle F; Delgado M
Arthritis Rheum; 2007 Feb; 56(2):531-43. PubMed ID: 17265488
[TBL] [Abstract][Full Text] [Related]
4. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
Gonzalez-Rey E; Anderson P; González MA; Rico L; Büscher D; Delgado M
Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
[TBL] [Abstract][Full Text] [Related]
5. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis.
Zhou B; Yuan J; Zhou Y; Ghawji M; Deng YP; Lee AJ; Lee AJ; Nair U; Kang AH; Brand DD; Yoo TJ
Clin Immunol; 2011 Dec; 141(3):328-37. PubMed ID: 21944669
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders.
Parolini O; Souza-Moreira L; O'Valle F; Magatti M; Hernandez-Cortes P; Gonzalez-Rey E; Delgado M
Arthritis Rheumatol; 2014 Feb; 66(2):327-39. PubMed ID: 24504805
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis.
Gonzalez-Rey E; Fernandez-Martin A; Chorny A; Delgado M
Arthritis Rheum; 2006 Mar; 54(3):864-76. PubMed ID: 16508968
[TBL] [Abstract][Full Text] [Related]
8. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells.
Cao Q; Wang L; Du F; Sheng H; Zhang Y; Wu J; Shen B; Shen T; Zhang J; Li D; Li N
Cell Res; 2007 Jul; 17(7):627-37. PubMed ID: 17563757
[TBL] [Abstract][Full Text] [Related]
10. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis.
Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F
Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
12. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of a novel DNA vaccine that is potent antigen-specific tolerizing therapy for experimental arthritis by increasing CD4+CD25+Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Song X; Liang F; Liu N; Luo Y; Xue H; Yuan F; Tan L; Sun Y; Xi C; Xi Y
Vaccine; 2009 Jan; 27(5):690-700. PubMed ID: 19095031
[TBL] [Abstract][Full Text] [Related]
14. The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.
Frey O; Petrow PK; Gajda M; Siegmund K; Huehn J; Scheffold A; Hamann A; Radbruch A; Bräuer R
Arthritis Res Ther; 2005; 7(2):R291-301. PubMed ID: 15743476
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses.
Gonzalez-Rey E; Chorny A; Del Moral RG; Varela N; Delgado M
Ann Rheum Dis; 2007 May; 66(5):582-8. PubMed ID: 17151007
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis.
Park MJ; Park HS; Cho ML; Oh HJ; Cho YG; Min SY; Chung BH; Lee JW; Kim HY; Cho SG
Arthritis Rheum; 2011 Jun; 63(6):1668-80. PubMed ID: 21384335
[TBL] [Abstract][Full Text] [Related]
18. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis.
van Hamburg JP; Mus AM; de Bruijn MJ; de Vogel L; Boon L; Cornelissen F; Asmawidjaja P; Hendriks RW; Lubberts E
Arthritis Rheum; 2009 Mar; 60(3):750-9. PubMed ID: 19248112
[TBL] [Abstract][Full Text] [Related]
19. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
[TBL] [Abstract][Full Text] [Related]
20. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M; Rozieres A; Hennino A; Poyet G; Gaillard V; Renaudineau S; Achachi A; Benetiere J; Kaiserlian D; Dubois B; Nicolas JF
J Allergy Clin Immunol; 2010 Aug; 126(2):280-9, 289.e1-7. PubMed ID: 20624644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
